|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-10-20
|
|
pubmed:abstractText |
The cobas TaqScreen West Nile virus (WNV) test (Roche Molecular Systems) was licensed by the Food and Drug Administration (FDA) in August 2007 for detecting WNV RNA in pools of six or in individual donations (IDs). A series of studies established the performance characteristics of the assay and test system before FDA licensure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1537-2995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2184-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18694466-Blood Donors,
pubmed-meshheading:18694466-Canada,
pubmed-meshheading:18694466-Genetic Testing,
pubmed-meshheading:18694466-Humans,
pubmed-meshheading:18694466-Mass Screening,
pubmed-meshheading:18694466-RNA, Viral,
pubmed-meshheading:18694466-Reproducibility of Results,
pubmed-meshheading:18694466-Sensitivity and Specificity,
pubmed-meshheading:18694466-West Nile Fever,
pubmed-meshheading:18694466-West Nile virus
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay.
|
|
pubmed:affiliation |
From Roche Molecular Systems, Pleasanton, California 94588, USA.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies,
Validation Studies
|
